2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Dow Jones2026/09/15 02:10Current Spread in Yield Basis Points
U.S. 4.673 % Australia 5.031 % 35.8 Belgium 3.292 % -138.1 Canada 3.389 % -128.4 Denmark 3.072 % -160.1 France 3.524 % -114.9 Germany 3.271 % -140.2 Italy 3.492 % -118.1 Japan 1.847 % -282.6 Netherlands 3.266 % -140.7 Spain 3.336 % -133.7 Sweden 2.764 % -190.9 U.K. 4.770 % 9.7
Source: Tullett Prebon via FactSet
(END) Dow Jones Newswires
September 14, 2026 22:10 ET (02:10 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
